All compounds are strictly intended for in vitro scientific and laboratory research only — not for human or animal use. By entering you confirm you are 21 or older and will comply with all applicable laws.
The full spectrum. Five compounds. One protocol. Built for the serious researcher who demands the most comprehensive compound stack available. For in vitro laboratory research use only.
PT-141 and Oxytocin studied together for their roles in reward pathway activation and social bonding mechanisms. Research explores how MC4R agonism and neuropeptide signaling intersect in intimacy and connection-related pathways. For in vitro laboratory research use only.
Melanotan II studied for MC1R/MC4R-mediated melanogenesis and UV-independent pigmentation pathways. Paired with GHK-Cu, researched for dermal collagen synthesis and skin matrix remodeling. A dual-compound approach to pigmentation and skin integrity research. For in vitro laboratory research use only.
NAD+ studied for mitochondrial function, sirtuin activation, and DNA repair pathway research. Paired with MOTS-C, a mitochondrial-derived peptide researched for its role in metabolic regulation and cellular energy homeostasis. For in vitro laboratory research use only.
GLOW 70mg — Future Form's proprietary dermatological blend studied for luminosity, pigmentation regulation, and cellular turnover. Paired with NAD+ for cellular repair and metabolic pathway research at the skin level. Clean. Precise. For in vitro laboratory research use only.
DSIP studied for its role in sleep architecture modulation and neuroendocrine signaling pathways. Paired with NAD+ researched for cellular energy restoration and DNA repair mechanisms. A compound pairing built around recovery and regeneration research. For in vitro laboratory research use only.
Semax studied for BDNF upregulation and neuroprotective signaling in cognitive research models. Selank researched for anxiolytic pathway modulation and GABAergic system interaction. Together, one of the most studied nootropic pairings in peptide research. For in vitro laboratory research use only.
CJC-1295/Ipamorelin blend studied for GHRH receptor signaling and pulsatile growth hormone release mechanisms. Paired with IGF1-LR3 — an extended half-life IGF-1 analogue researched for downstream anabolic receptor signaling and muscle tissue growth factor pathways. For in vitro laboratory research use only.
Retatrutide studied as a triple GLP/GIP/glucagon receptor agonist for metabolic pathway research. Paired with Tesamorelin, a GHRH analogue researched for visceral adipose reduction mechanisms and growth hormone axis support. For in vitro laboratory research use only.
Semaglutide studied for GLP-1 receptor agonism and glycemic pathway modulation. Paired with GLP3-RT, a third-generation GLP receptor analogue researched for energy homeostasis and advanced metabolic pathway signaling. Next-level GLP research in one bundle. For in vitro laboratory research use only.
Retatrutide studied for simultaneous GLP-1, GIP, and glucagon receptor engagement — the most comprehensive GLP pathway compound in current research. Paired with Cagrilintide, an amylin analogue researched for appetite signaling and energy balance mechanisms. For in vitro laboratory research use only.